- Home
- PTGX vs ABR Comparison
PTGX vs ABR Comparison
Compare PTGX & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- ABR
- Stock Information
- Founded
- PTGX 2006
- ABR 2003
- Country
- PTGX United States
- ABR United States
- Employees
- PTGX N/A
- ABR N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- ABR Real Estate Investment Trusts
- Sector
- PTGX Health Care
- ABR Real Estate
- Exchange
- PTGX Nasdaq
- ABR Nasdaq
- Market Cap
- PTGX 2.7B
- ABR 2.7B
- IPO Year
- PTGX 2016
- ABR 2004
- Fundamental
- Price
- PTGX $41.49
- ABR $13.78
- Analyst Decision
- PTGX Strong Buy
- ABR Hold
- Analyst Count
- PTGX 8
- ABR 6
- Target Price
- PTGX $54.63
- ABR $14.25
- AVG Volume (30 Days)
- PTGX 767.3K
- ABR 2.1M
- Earning Date
- PTGX 11-07-2024
- ABR 02-14-2025
- Dividend Yield
- PTGX N/A
- ABR 12.50%
- EPS Growth
- PTGX N/A
- ABR N/A
- EPS
- PTGX 2.68
- ABR 1.35
- Revenue
- PTGX $323,795,000.00
- ABR $650,354,000.00
- Revenue This Year
- PTGX $441.08
- ABR N/A
- Revenue Next Year
- PTGX N/A
- ABR N/A
- P/E Ratio
- PTGX $15.46
- ABR $10.18
- Revenue Growth
- PTGX 125.73
- ABR N/A
- 52 Week Low
- PTGX $21.43
- ABR $11.92
- 52 Week High
- PTGX $48.89
- ABR $16.35
- Technical
- Relative Strength Index (RSI)
- PTGX 48.12
- ABR 34.33
- Support Level
- PTGX $38.61
- ABR $13.65
- Resistance Level
- PTGX $41.18
- ABR $14.55
- Average True Range (ATR)
- PTGX 1.93
- ABR 0.34
- MACD
- PTGX -0.01
- ABR -0.05
- Stochastic Oscillator
- PTGX 59.02
- ABR 25.70
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.